Reset filters
  • 27 September 2010

HIV treatment is costly, especially for the sickest patients

Read the article
Image: Africa Studio/Shutterstock.com
  • 27 September 2010

High long-term economic costs associated with late HIV diagnosis

Read the article
  • 23 September 2010

FTC therapy reduces risk of important resistance mutation

Read the article
  • 22 September 2010

Early warning indicators for drug resistance in resource-limited settings piloted in Namibia

Read the article
  • 22 September 2010

Darunavir/ritonavir as effective in women as men

Read the article
  • 20 September 2010

Longer viral load is undetectable, lower the risk of rebound

Read the article
  • 17 September 2010

Switch to nevirapine can happen at any CD4 count, says European drug regulator

Read the article
  • 14 September 2010

HIV/HCV co-infected women more likely to stop HCV therapy

Read the article
  • 9 September 2010

Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.